Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning. 1998

D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
University of Patras Medical School, Regional University Hospital of Patras, Greece.

The efficacy of 99mTc-tetrofosmin for the detection of parathyroid lesions was investigated prospectively in patients with hyperparathyroidism referred for surgical treatment. METHODS Twenty-seven patients with primary and 18 with tertiary hyperparathyroidism were studied. Twelve patients had undergone one or more previous neck explorations. Static imaging with 201Tl was performed first, immediately followed by a 30-min 99mTc-tetrofosmin dynamic study. Delayed views of up to 3 hr postinjection were also obtained. Technetium-99m-pertechnetate was used for thyroid delineation. The tetrofosmin/99mTc-pertechnetate subtraction scan (TF/TC), the single-tracer washout technique and the thallium/technetium subtraction (TL/TC) were compared. Quantification of relative uptakes of tracers in the thyroid and abnormal parathyroids was accomplished by measuring activity within regions of interest. Kinetics of tetrofosmin in the thyroid and abnormal parathyroids were studied by evaluating the plots of the parathyroid to thyroid ratios against time as well as by calculation of the half-clearance times from the slow component of the time-activity curves. RESULTS The overall sensitivity, specificity and accuracy of TF/TC and TL/TC were 76%, 92% and 83% and 52%, 85% and 65%, respectively. The respective sensitivities were 87% and 70% for adenomas and 72% and 46% for hyperplasia. The parathyroid-to-thyroid activity ratios of tetrofosmin were significantly higher than those of thallium (p < 0.001). The tetrofosmin single-tracer washout study was less accurate than the subtraction technique (overall sensitivity and specificity, 70% and 69%, respectively). The washout properties of tetrofosmin in abnormal parathyroids were not substantially different from those in the thyroid, with a few exceptions (p = 0.4). No correlation of half-clearance times with parathyroid size, degree of early uptake, parathyroid hormone levels or histology could be established. Comparing adenomas to hyperplasia in respect to tetrofosmin retention, a statistically significant difference was observed (p = 0.005). CONCLUSIONS Technetium-99m-tetrofosmin is suitable for parathyroid imaging. The kinetic properties of this agent in parathyroid and thyroid tissues do not warrant differential washout protocols. The diagnostic impact of the observed difference in tetrofosmin kinetics between parathyroid adenomas and hyperplasia requires further investigation.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010280 Parathyroid Glands Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. Gland, Parathyroid,Glands, Parathyroid,Parathyroid Gland
D010282 Parathyroid Neoplasms Tumors or cancer of the PARATHYROID GLANDS. Cancer of Parathyroid,Parathyroid Cancer,Cancer of the Parathyroid,Neoplasms, Parathyroid,Parathyroid Adenoma,Parathyroid Carcinoma,Adenoma, Parathyroid,Adenomas, Parathyroid,Cancer, Parathyroid,Cancers, Parathyroid,Carcinoma, Parathyroid,Carcinomas, Parathyroid,Neoplasm, Parathyroid,Parathyroid Adenomas,Parathyroid Cancers,Parathyroid Carcinomas,Parathyroid Neoplasm
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D005260 Female Females

Related Publications

D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
June 1996, European journal of nuclear medicine,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
June 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
March 1997, European journal of nuclear medicine,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
December 2001, European journal of nuclear medicine,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
January 1997, Anticancer research,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
January 2001, Anticancer research,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
September 1988, Archives of otolaryngology--head & neck surgery,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
February 1996, Annals of nuclear medicine,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
June 1989, The British journal of radiology,
D J Apostolopoulos, and E Houstoulaki, and C Giannakenas, and T Alexandrides, and J Spiliotis, and G Nikiforidis, and J G Vlachojannis, and P J Vassilakos
December 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!